A novel library of -arylketones as potential inhibitors of α-glucosidase: Their design, synthesis, in vitro and in vivo studies
Autor: | Uma Adepally, Tania Luthra, Subhabrata Sen, Rahul Agarwal, Mamidala Estari |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
Male
0301 basic medicine Magnetic Resonance Spectroscopy Brush border lcsh:Medicine 01 natural sciences Article Diabetes Mellitus Experimental Structure-Activity Relationship 03 medical and health sciences In vivo medicine Animals Hypoglycemic Agents Glycoside Hydrolase Inhibitors Rats Wistar lcsh:Science IC50 Acarbose chemistry.chemical_classification Multidisciplinary Molecular Structure 010405 organic chemistry Chemistry lcsh:R alpha-Glucosidases Streptozotocin Yeast In vitro Rats 0104 chemical sciences Molecular Docking Simulation 030104 developmental biology Enzyme Biochemistry lcsh:Q medicine.drug |
Zdroj: | Scientific Reports, Vol 7, Iss 1, Pp 1-13 (2017) Scientific Reports |
ISSN: | 2045-2322 |
DOI: | 10.1038/s41598-017-13798-y |
Popis: | α-glucosidase is an essential enzyme located at the brush border of intestines. It is an important therapeutic target for type II diabetes. Herein we have designed a library of novel α-arylketones as inhibitors of α-glucosidase (yeast origin) via scaffold hopping and bioisosteric modification of known inhibitors of α-glucosidase. The design was validated through molecular docking that revealed strong binding interactions of the newly designed compounds against α-glucosidase. A library comprising of 15 compounds was synthesized in a combinatorial fashion, where the advanced amide intermediates were accessed through “shot gun” synthesis. The final compounds were characterized by 1H, 13C-NMR and with high resolution mass spectroscopy. In vitro screening of the compounds against yeast α-glucosidase revealed substantial inhibition with IC50s in the range of 4–10 μM (the standard drug acarbose inhibits α-glucosidase with an IC50 of 9.95 μM). Reaction kinetics suggested mixed type inhibition. Finally, in vivo studies of the most active compound 3c against Streptozotocin induced male albino Wistar rats revealed that its administration in the rats for about 4 weeks lead to a highly significant (P 3c had better control over FBG in contrast to high-dose. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |